• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation.

作者信息

Miyata Toshio, van Ypersele de Strihou Charles

机构信息

Institute of Medical Sciences and Department of Medicine, Tokai, University School of Medicine, Kanagawa, Japan.

出版信息

Arch Biochem Biophys. 2003 Nov 1;419(1):50-4. doi: 10.1016/j.abb.2003.08.010.

DOI:10.1016/j.abb.2003.08.010
PMID:14568008
Abstract
摘要

相似文献

1
Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation.血管紧张素 II 受体阻滞剂和血管紧张素转换酶抑制剂：自由基清除和过渡金属螯合在抑制晚期糖基化终产物形成中的作用
Arch Biochem Biophys. 2003 Nov 1;419(1):50-4. doi: 10.1016/j.abb.2003.08.010.
2
Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms.血管紧张素 II 受体拮抗剂和血管紧张素转换酶抑制剂在体外可降低晚期糖基化终产物的形成：生化机制
J Am Soc Nephrol. 2002 Oct;13(10):2478-87. doi: 10.1097/01.asn.0000032418.67267.f2.
3
Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications.螯合作用：AGE 抑制剂、AGE 断裂剂和其他糖尿病并发症抑制剂的基本作用机制。
Diabetes. 2012 Mar;61(3):549-59. doi: 10.2337/db11-1120.
4
[Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy].[羰基应激抑制剂用于糖尿病肾病的新治疗干预措施]
Nihon Rinsho. 2004 May;62 Suppl 5:389-92.
5
Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.夏枯草提取物对晚期糖基化终产物形成及代谢综合征相关关键酶的抑制作用。
Molecules. 2017 Oct 21;22(10):1785. doi: 10.3390/molecules22101785.
6
Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering.血管紧张素受体阻滞剂除降压之外的肾脏保护特性。
J Am Soc Nephrol. 2005 Dec;16(12):3631-41. doi: 10.1681/ASN.2005050522. Epub 2005 Oct 19.
7
Aged garlic has more potent antiglycation and antioxidant properties compared to fresh garlic extract in vitro.与新鲜大蒜提取物相比，陈蒜在体外具有更强的抗糖化和抗氧化特性。
Sci Rep. 2017 Jan 4;7:39613. doi: 10.1038/srep39613.
8
Advanced glycation end-products inhibitors isolated from Schisandra grandiflora.从大花五味子中分离得到的晚期糖基化终产物抑制剂。
Nat Prod Res. 2016;30(4):493-6. doi: 10.1080/14786419.2015.1024117. Epub 2015 Mar 27.
9
Novel inhibitors of advanced glycation endproducts.晚期糖基化终产物的新型抑制剂
Arch Biochem Biophys. 2003 Nov 1;419(1):63-79. doi: 10.1016/j.abb.2003.08.009.
10
Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.膳食晚期糖基化终产物和药物影响长期1型糖尿病患者外周血单个核细胞中SIRT1和DDOST的表达。
Diab Vasc Dis Res. 2018 Jan;15(1):81-89. doi: 10.1177/1479164117733918. Epub 2017 Oct 13.

引用本文的文献

1
Synthesis, Characterization, Antiglycation Evaluation, Molecular Docking, and ADMET Studies of 4-Thiazolidinone Derivatives.4-噻唑烷酮衍生物的合成、表征、抗糖化评估、分子对接及ADMET研究
ACS Omega. 2023 Dec 28;9(1):1810-1820. doi: 10.1021/acsomega.3c08463. eCollection 2024 Jan 9.
2
Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease.指尖测量的晚期糖基化终产物与心血管疾病门诊患者心血管事件的关系。
Cardiovasc Diabetol. 2023 Aug 17;22(1):213. doi: 10.1186/s12933-023-01953-x.
3
Glycyrrhizic Acid Scavenges Reactive Carbonyl Species and Attenuates Glycation-Induced Multiple Protein Modification: An and Study.
甘草酸清除反应性羰基物种并减轻糖基化诱导的多种蛋白质修饰：一项体内和体外研究。
Oxid Med Cell Longev. 2021 Oct 11;2021:7086951. doi: 10.1155/2021/7086951. eCollection 2021.
4
Association of Novel Advanced Glycation End-Product (AGE10) with Complications of Diabetes as Measured by Enzyme-Linked Immunosorbent Assay.通过酶联免疫吸附测定法检测新型晚期糖基化终末产物（AGE10）与糖尿病并发症的关联。
J Clin Med. 2021 Sep 29;10(19):4499. doi: 10.3390/jcm10194499.
5
Advanced Glycation End Products: New Clinical and Molecular Perspectives.糖基化终产物：新的临床与分子视角。
Int J Environ Res Public Health. 2021 Jul 6;18(14):7236. doi: 10.3390/ijerph18147236.
6
Dietary Metabolites and Chronic Kidney Disease.饮食代谢物与慢性肾脏病
Nutrients. 2017 Apr 4;9(4):358. doi: 10.3390/nu9040358.
7
Effects of olmesartan on arterial stiffness in rats with chronic renal failure.奥美沙坦对慢性肾衰竭大鼠动脉僵硬的影响。
Cardiovasc Diabetol. 2012 Jun 13;11:66. doi: 10.1186/1475-2840-11-66.
8
Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications.螯合作用：AGE 抑制剂、AGE 断裂剂和其他糖尿病并发症抑制剂的基本作用机制。
Diabetes. 2012 Mar;61(3):549-59. doi: 10.2337/db11-1120.
9
Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.晚期糖基化终产物：心肾综合征的病理生理学途径。
Heart Fail Rev. 2012 Mar;17(2):221-8. doi: 10.1007/s10741-010-9225-z.
10
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.评估糖尿病中晚期糖基化终产物积累的临床相关性。
Cardiovasc Diabetol. 2008 Oct 7;7:29. doi: 10.1186/1475-2840-7-29.